Director of Hospital Medicine Research in the Division of General Internal Medicine
University of Utah, Salt Lake City, USA
Consultant Antimicrobial Pharmacist
Royal Cornwall Hospitals NHS Trust, Truro, UK
Procalcitonin (PCT) is a biomarker widely used to assess the risk of bacterial infection and to aid in antibiotic stewardship in patients with lower respiratory tract infections (LRTI) and sepsis.
Evolving evidence now demonstrates that PCT can also be a valuable tool in the current COVID-19 pandemic to aid in early identification of patients at low risk of bacterial co-infection on admission as well as assist in the detection of bacterial superinfection in hospitalized patients.
Dr. Valerie Vaughn (University of Utah, USA) and Dr. Neil Powell (Royal Cornwall Hospitals NHS Trust, UK) share the latest information and own experience on the role of Procalcitonin (PCT) in the management of these critical patients.
A Certificate of Attendance will be sent to participants.
Bacterial coinfections as risk factor in COVID-19 patients - how does the pandemic impact antibiotic prescription?
Results from multicentric study on how a more rational use of antibiotics in COVID-19 patients could be achieved
Dr. Valerie Vaughn, University of Utah, USA
Procalcitonin as a tool for differential diagnosis of bacterial infection and antibiotic stewardship in LRTI
First experience on its utility for antibiotic stewardship in COVID-19 patients
Dr. Neil Powell, Royal Cornwall Hospitals NHS Trust, UK
Mon, 12 Apr 2021 - Fri, 16 Apr 2021
Sun, 25 Apr 2021 - Fri, 30 Apr 2021
Tue, 11 May 2021 - Fri, 14 May 2021
Thu, 17 Jun 2021 - Sat, 19 Jun 2021
Wed, 23 Jun 2021 - Sat, 26 Jun 2021
Sat, 17 Jul 2021 - Wed, 21 Jul 2021